SINGLEJECT
USPTO Trademark Record · Serial No. 74663645
Trademark details
It was initially claimed by Amgen Inc. on 19950420.
That brand applies to the following goods and services:pharmaceutical preparation sold in prefilled syringes for use in connection with one or more of the following - the treatment of viral, neoplastic and autoimmune diseases; treatment of neurological disorders; for stimulating white blood cell production; for stimulating red blood cell production; and for increasing platelet count.
Currently that trademark is represented by trademark attorney(s): Mark I. Feldman, Christina L. Martini.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the SINGLEJECT trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
